PCSK9 inhibitor Archives - Cardiovascular News

The European Commission authorise use of evolocumab to reduce risk of myocardial infarction in patients with established cardiovascular disease

31st May 2018

The European Commissi...

ADVERTORIAL: Taking control of LDL-C when statin therapy is not enough

25th May 2018

This content is for distr...

ACC 2017: PCSK9 inhibitor evolocumab significantly reduces the risk of cardiovascular events

21st March 2017

Data for a new drug t...

AHA 2016: The Medicines Company and Alnylam Pharmaceuticals present positive results from ORION-1 phase 2 study of their PCSK9 inhibitor inclisiran

16th November 2016

The Medicines Company and...

Pfizer discontinues the global development of its investigational PCSK9 inhibitor

9th November 2016

Pfizer is to discontinue ...

Write to us
Editorial: Will Date will@bibamedical.com
Advertising: Hannah Shiels hannah@bibamedical.com

BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: info@bibamedical.com

Terms and Conditions | Privacy Policy